Compounders Research Compare

Clearmind Medicine Inc.(CMND)

Biotechnology · Vancouver, BC

$5.80-0.20 (-3.34%)

Delayed quote: Oct 6, 2026, 9:34 AM EDT

About Clearmind Medicine Inc.

Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions. The company's research targets conditions such as alcohol use disorder (including problematic binge drinking), various eating disorders (like binge eating), depression, and other compulsive or "binge" behaviors. Founded in 2017, the company initially operated under the name Cyntar Ventures Inc. before officially rebranding as Clearmind Medicine Inc. in March 2021. Its operations are headquartered in Vancouver, Canada.

Vancouver, BC

4 employees

www.clearmindmedicine.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Adi Zuloff-Shani

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T13:36:05.721Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:36:05.721Z.

Quote observation: 2026-10-06T13:34:59.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-07-31: -89.2
Quote price: 5.7995

FMP input reference: 003104a745df447911be4c5a9e680832c7b19445192e606e8359fbce1df4db86

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

CMND Earnings Yield Metrics

EARNINGS YIELD

N/A

CMND Competitors' Earnings Yield

Clearmind Medicine Inc.

Current

Market Cap

$1.08M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cellyan Biotechnology Co., Ltd

Market Cap

$1.14M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aspire Biopharma Holdings, Inc.

Market Cap

$1.01M

Earnings Yield

N/A

TTM Avg

0.00%

3Y Avg

0.00%

5Y Avg

0.00%

Jupiter Neurosciences, Inc.

Market Cap

$1.15M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IM Cannabis Corp.

Market Cap

$1.17M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GlucoTrack, Inc.

Market Cap

$901902.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Bone Biologics Corporation

Market Cap

$897948.00

Earnings Yield

N/A

TTM Avg

30990441.81%

3Y Avg

30990441.81%

5Y Avg

30990441.81%

Decoy Therapeutics Inc.

Market Cap

$872428.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Bluejay Diagnostics, Inc.

Market Cap

$800351.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Artelo Biosciences, Inc.

Market Cap

$1.38M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Clearmind Medicine Inc. (CMND)	$1.08M	N/A	N/A	N/A	N/A
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.14M	N/A	N/A	N/A	N/A
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.01M	N/A	0.00%	0.00%	0.00%
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.15M	N/A	N/A	N/A	N/A
IM Cannabis Corp. (IMCC)vs ›	$1.17M	N/A	N/A	N/A	N/A
GlucoTrack, Inc. (GCTK)vs ›	$901902.00	N/A	N/A	N/A	N/A
Bone Biologics Corporation (BBLG)vs ›	$897948.00	N/A	30990441.81%	30990441.81%	30990441.81%
Decoy Therapeutics Inc. (DCOY)vs ›	$872428.00	N/A	N/A	N/A	N/A
Bluejay Diagnostics, Inc. (BJDX)vs ›	$800351.00	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.38M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics